Yu et al. [21] demonstrated that elevated KAT2A expression correlates with immune microenvironment infiltration, malignant progression, and reduced survival rates in diffuse large B-cell lymphoma. The gene discussed is KAT2A; the disease is diffuse large B-cell lymphoma.